Wrap up: dvm360 honors 2025 Hospital Design360 competition merit winners, and other news

Happy Friday dvm360 readers! We hope each of you had a fantastic week and, if it applies to you, have a safe long holiday weekend. Now that we have wrapped up the 2025 Fetch Kansas City Conference, we are over the moon to be heading to Fetch National Harbor in just a few weeks! Join us for our very first Fetch National Harbor and follow along with our coverage on dvm360.com.

chendongshan/stock.adobe.com

Here is what was popular this week on dvm360.com:

• This week dvm360 honored the 8 veterinary practices that received merit awards for dvm360’s 2025 Hospital Design Competition. You can check out the hospitals and learn more about each here.
• The latest installment of dvm360's Vet Scene Down Under is now available. dvm360’s Australian correspondent Phil Tucak, BSc, BVMS, shared more on how biosecurity project in remote Indigenous communities exceeded expectations, a free mediation opportunity for veterinary professionals, and more.
• On this episode of Vet Watch, Christopher Lee, DVM, MPH, DACVPM, welcomed back Alice Jeromin, DVM, RPh, DACVD, to the show to talk about itchy pets and skin allergy testing, plus why it is crucial to properly interpret a client's history
• A recent survey that was conducted with 600 pet owners in the US showed pet owners are more concerned about their pet's emotional wellbeing than physical health, aggression, or disobedience. Conducted between July 3, 2025 and July 9, 2025, the survey also showed pet separation anxiety was the top concern among 61% of participating pet owners.
• The FDA announced this week that it has approved a generic gamithromycin injectable solution (Gamrozyne; Bimedia Animal Health) to treat bovine respiratory diseases associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and nonlactating dairy cattle
• And more!